Abranilla, Baby Girl .

HRN: 26-63-00  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/05/2025
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
03/05/2025
03/11/2025
IV
25mg As LD Then 12mg Q24h
Q24h
Fungal Infection
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: